Related Experiment Video
Updated: Aug 27, 2025
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
The Epidemiological Characteristics and Outcome of COVID-19 in Patients Undergoing Peritoneal Dialysis: A
Jalal Azmandian, Zahra Shafii1, Shahrokh Ezzatzadegan Jahromi
1Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. shafii_zahra@yahoo.com.
Insights
COVID-19 poses a high mortality risk for peritoneal dialysis (PD) patients, despite a low incidence. Close contact and reduced protective equipment use were common infection causes. Vaccination and prevention are crucial for PD patients.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic, originating in December 2019, presents significant challenges, particularly for individuals with pre-existing conditions.
- Understanding the clinical impact of COVID-19 on patients with underlying diseases remains a critical public health concern.
Purpose of the Study:
- To investigate the clinical manifestations and outcomes of COVID-19 in patients undergoing peritoneal dialysis (PD).
Main Methods:
- A multicenter cohort study involving 505 patients receiving peritoneal dialysis.
- Data collection focused on COVID-19 infection rates, symptoms, hospitalization, intensive care unit (ICU) admission, and mortality.
Main Results:
- 3.7% of PD patients contracted coronavirus infection.
- Fever was the most frequent symptom (63.2%).
- Hospitalization occurred in 10.5% of cases, with 21.1% requiring ICU admission and a concerning 21% mortality rate.
Conclusions:
- While the incidence of COVID-19 in PD patients is low, the disease severity and mortality rates are notably high.
- Close contact with infected individuals and inadequate use of protective equipment were identified as primary infection sources.
- Vaccination and strict adherence to preventive measures are strongly advised for peritoneal dialysis patients to mitigate risks.
Abstract:
The pandemic of COVID-19 emerged in December 2019. Although numerous features of the illness have been investigated, the impact of disease on those patients with underlying diseases, is still a major problem. The aim of this multicenter, cohort study, was to determine the clinical manifestations of COVID-19 in peritoneal dialysis (PD) patients. Five hundred and five patients, receiving PD, were enrolled in this study, out of which 3.7% had coronavirus infection. Fever was the most common symptom (63.2%). The hospitalization rate was 10.5, 21.1% required admission to intensive care units (ICU) and the mortality rate was 21%. The most common cause of infection included close contact with the infected individuals and lower rates of protective equipment use. Although the incidence of COVID-19 among PD patients is low, the severity of the disease and the mortality rate are quite high. Vaccination and adherence to preventive measures are strongly recommended in PD patients. DOI: 10.52547/ijkd.7147.
Related Concept Videos
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
01:25Peritoneal Dialysis III: Nursing Management
01:30Peritoneal Dialysis I: Introduction and Procedure
01:27Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
01:24Hemodialysis II: Procedure and Complications
01:25Hemodialysis I: Introduction